Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2 Flora
- Development stage
- Unknown
- Lead developer
- McW Healthcare
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
2 Flora is a probiotic and prebiotic (synbiotic) supplement developed and marketed by McW Healthcare. It is formulated as an oral capsule containing a combination of beneficial bacterial strains, specifically *Lactobacillus acidophilus* (1 billion CFU) and *Bifidobacterium bifidum* (1 billion CFU), along with the prebiotic fructooligosaccharides (FOS, 100 mg). 2 Flora is used to support gastrointestinal health, restore and maintain healthy gut microbiota, and manage digestive disorders such as diarrhea (including antibiotic-associated diarrhea), irritable bowel syndrome (IBS), and indigestion. The probiotic strains help replenish beneficial gut flora, while the prebiotic FOS selectively promotes the growth and colonization of these beneficial bacteria in the digestive tract.
- Brand names
- 2 Flora
- Other names
- 2 Flora Capsule2Flora
Beyond the preview
Go deeper on 2 Flora.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2 Flora.